Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SKP2 |
| Upstream (Parents) |
|---|
| (<<) TPSB2///TPSAB1 → SKP2 |
| (<<) MAPK14 → SKP2 |
| (<<) NCOA2 → SKP2 |
| (<<) CDH1 → SKP2 |
| (<<) ATP13A3 → SKP2 |
| Downstream (Children) |
|---|
| SKP2 → HMGB3L1 (>>) |
| SKP2 → ZNF780A///ZNF780B (>>) |
| SKP2 → SYT1 (>>) |
| SKP2 → NLRP2 (>>) |
| SKP2 → TXNDC3 (>>) |
| SKP2 → CCK (>>) |
| SKP2 → GYPE (>>) |
| SKP2 → B4GALT1 (>>) |
| SKP2 → MAPK14 (>>) |
| SKP2 → NCOA2 (>>) |
| SKP2 → HMGCS1 (>>) |
| SKP2 → STAC (>>) |
| SKP2 → CDH1 (>>) |
| SKP2 → UTP18 (>>) |
